This report is no longer available. Click here to view our current reports or contact us to discuss a custom report.

If you have previously purchased this report then please use the download links on the right to download the files.

Bioelectronic Medicine 2019-2029

Focus on emerging technologies for electrical neuromodulation, including spinal cord stimulators, deep brain stimulators, vagus nerve stimulators, trigeminal nerve stimulators and more

Show All Description Contents, Table & Figures List FAQs Pricing Related Content
Bioelectronic medicine, or electroceuticals, is the use of electrical stimulation to treat diseases of the human body in ways that current pharmaceutical interventions cannot. Though the term "bioelectronic medicine" is relatively new, electrical stimulation has been used for the treatment of diseases since the invention of the artificial pacemaker in the early 1900s.
 
From the development of the implantable artificial pacemaker, the field of bioelectronic medicine has expanded into the treatment of many other diseases. This report focuses on emerging areas of electrical neuromodulation, or the application of electrical stimulation to specific nerves within human body. Electrical neuromodulation has been used to treat illnesses such as chronic pain and Parkinson's disease, and can be used to restore function to muscles, as well as the senses of hearing and sight.
 
Electrical neuromodulation began in the 1960s with the development of stimulators for the central nervous system. The spinal cord and areas of the brain were targeted for the treatment of chronic pain and movement disorders respectively. Both fields have remained relatively unchanged in the last 30 years, and thus this report explores the emerging technologies that are disrupting this industry.
 
More recently, there has been increasing interest in developing bioelectronic medicine that modulates the peripheral nervous system. In this area, companies are particularly interested in electrical neuromodulation of the vagus nerve. Leading this effort are SetPoint Medical and Galvani Bioelectronics, two high profile companies which have been backed by industry giants in the medical device, technology, and pharmaceutical industries. Modulation of the vagus nerve promises to treat a myriad of diseases, including diabetes and rheumatoid arthritis.
 
Bioelectronic medicines have enormous opportunities in the treatment of chronic diseases and disorders, especially if they can replace traditional pharmaceutical medicines. Innovators in the field are driving down the size of components and improving electrode technologies to provide greater patient comfort and less invasive implantation procedures. Others are exploring non-invasive devices that can provide electrical neuromodulation through the skin.
 
This report provides an overview of devices for cardiac rhythm management, cochlear implants, and retinal implants, and gives a comprehensive analysis of companies developing electrical neuromodulators of both the central and peripheral nervous systems. Included in this report are devices that stimulate the spinal cord (including dorsal root ganglion), brain, vagus nerve, sacral nerve, tibial nerve, trigeminal nerve, and many others.
 
In this report, the market for bioelectronic medicine is forecast to exceed $60 billion by the year 2029. The 10-year market forecast is broken down into individual markets of cardiac, cochlear, retinal, central nervous system and peripheral nervous system implants.
Analyst access from IDTechEx
All report purchases include up to 30 minutes telephone time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.
Further information
If you have any questions about this report, please do not hesitate to contact our report team at research@IDTechEx.com or call one of our sales managers:

AMERICAS (USA): +1 617 577 7890
ASIA (Japan and Korea): +81 3 3216 7209
EUROPE (UK) +44 1223 812300
1.EXECUTIVE SUMMARY
1.1.Bioelectronic Medicine
1.2.Major Forms of Bioelectronic Medicine
1.3.The Nervous System
1.4.Bioelectronic Medicine Market Forecast 2019 - 2029
1.5.Bioelectronic Medicine Market Breakdown 2019 vs 2029
1.6.Cardiac Rhythm Management and Heart Failure
1.7.Cardiac Market Forecast 2019 - 2029
1.8.Cochlear and Retinal Implant Market Forecast 2019 - 2029
1.9.Electrical Neuromodulation of the Central Nervous System
1.10.CNS Market Forecast 2019 - 2029
1.11.Pharmaceuticals vs Electroceuticals
1.12.The Reach of Peripheral Nerve Stimulation is Vast
1.13.Electrical Neuromodulation of the Peripheral Nervous System
1.14.Moving to First Line Therapy
1.15.Next Generation Devices
2.INTRODUCTION
2.1.Bioelectronic Medicine: Definition and Scope of Report
2.2.Major Forms of Bioelectronic Medicine
2.3.Initiation, Emergence, and Trends
2.4.The Evolution of Bioelectronic Medicine
2.5.Rise of Bioelectronic Medicine
2.6.Pharmaceuticals vs Electroceuticals
2.7.Bioelectronic Medicine as an Alternative to Opioids
2.8.The Nervous System
2.9.How Neurons Normally Function
2.10.How Neurons Normally Function - The Synaptic Cleft
2.11.Neuromodulation
2.12.Neuroprosthetics Defined
2.13.Re-Engineering Sight and Sound
2.14.Bioelectronic Device Components
2.15.Pulse Generators
2.16.Leads and Electrodes
2.17.Controllers and Chargers
2.18.MR Conditional
2.19.Rechargeable vs Recharge-Free vs No Batteries
2.20.Applications of Bioelectronic Medicine
2.21.Challenges to Next Generation Bioelectronic Medicine
3.MARKET TRENDS
3.1.Key Market Trends
3.2.Key Players: Established Applications
3.3.Abbott Acquires St Jude Medical
3.4.Key Players: Emerging Applications
3.5.GlaxoSmithKline
3.6.Galvani Bioelectronics
3.7.SetPoint Medical
3.8.Research Initiatives Drive Basic and Translational Research
3.9.The BRAIN Initiative
3.10.Stimulating Peripheral Activity to Relieve Conditions
3.11.ElectRx
3.12.Ageing Populations
3.13.The Impact of Sensory Loss
3.14.The Prevalence and Expected Rise of Macular Degeneration
3.15.Back Pain is a Major Cause of Disability
3.16.Challenges from Bench to Bedside
3.17.Regulatory: Invasiveness of the Device
3.18.Regulatory: CE Mark
3.19.New Regulations in the EU
3.20.Regulatory: FDA
3.21.Regulatory: FDA Timeline
3.22.Reimbursement
3.23.Moving to First Line Therapy
4.MARKET FORECAST
4.1.Introduction
4.2.Bioelectronic Medicine Market Forecast 2019 - 2029
4.3.Bioelectronic Medicine Market Breakdown 2019 vs 2029
4.4.Cardiac Market Forecast 2019 - 2029
4.5.Cochlear and Retinal Implant Market Forecast 2019 - 2029
4.6.Cochlear and Retinal Implant Market Breakdown 2019 vs 2029
4.7.CNS Market Forecast 2019 - 2029
4.8.PNS Market Forecast 2019 - 2029
4.9.PNS Market Forecast 2019 - 2029: Discussion
4.10.Ongoing Clinical Trials
5.APPLICATIONS
5.1.Cardiac Rhythm Management and Heart Failure
5.1.1.Introduction
5.1.2.Key Players
5.1.3.Cardiac Market 2013 - 2018
5.1.4.Devices and Indications
5.1.5.Components
5.1.6.Implantation Procedure
5.1.7.Bradycardia and Heart Block
5.1.8.Pacemakers
5.1.9.Leadless Pacemaker
5.1.10.Heart Failure
5.1.11.Cardiac Resynchronization Therapy
5.1.12.Implantable Cardioverter Defibrillators
5.1.13.Extravascular Cardioverter Defibrillator
5.1.14.Key Trends - Cardiac
5.1.15.Drivers and Constraints - Cardiac
5.2.Cochlear Implants
5.2.1.How We Hear Normally
5.2.2.Major Technological Developments in Cochlear Implants
5.2.3.Cochlear Implants
5.2.4.Outline of a Cochlear Implant
5.2.5.Special Considerations for Cochlear Implants
5.2.6.Major Players for Hearing Restoration
5.2.7.Cochlear
5.2.8.Advanced Bionics
5.2.9.MED-EL
5.2.10.Outlook - Cochlear Implants
5.3.Retinal Implants
5.3.1.How We See Normally
5.3.2.How We See with Retinal Degeneration
5.3.3.A Brief History of Vision Restoration
5.3.4.Artificial Retinas
5.3.5.Artificial Retinas - Epiretinal Implants
5.3.6.Artificial Retinas - Subretinal Implants
5.3.7.Intracortical Visual Prosthetics
5.3.8.Special Considerations for Vision
5.3.9.Major Players for Neuroprosthetic Sight Restoration
5.3.10.Second Sight Medical
5.3.11.Pixium Vision
5.3.12.Retina Implant
5.3.13.Outlook - Retinal Implants
5.4.Central Nervous System
5.4.1.Introduction
5.4.2.CNS Players
5.4.3.CNS Market 2013 - 2018
5.4.4.Spinal Cord and Dorsal Root Ganglion Stimulation
5.4.5.Deep Brain Stimulation
5.5.Peripheral Nervous System
5.5.1.Introduction
5.5.2.Players
5.5.3.PNS Market 2013 - 2018
5.5.4.Vagus Nerve Stimulation
5.5.5.Trigeminal Nerve Stimulation
5.5.6.Sacral Nerve Stimulation
5.5.7.Other Nerve Targets
5.5.8.Peripheral Nerve Stimulation for Chronic Pain
6.NEXT GENERATION DEVICES
6.1.Introduction
6.2.An Interdisciplinary Approach is Required
6.3.Visceral Nerve Atlas
6.4.Neural Interfacing Technology
6.5.Closed Loop Systems
6.6.Closed Loop Systems: Requirements
6.7.Outlook - Next Generation Devices
7.ACRONYMS
7.1.List of Acronyms
8.COMPANY PROFILES
 

About IDTechEx reports

What are the qualifications of the people conducting IDTechEx research?

Content produced by IDTechEx is researched and written by our technical analysts, each with a PhD or master's degree in their specialist field, and all of whom are employees. All our analysts are well-connected in their fields, intensively covering their sectors, revealing hard-to-find information you can trust.

How does IDTechEx gather data for its reports?

By directly interviewing and profiling companies across the supply chain. IDTechEx analysts interview companies by engaging directly with senior management and technology development executives across the supply chain, leading to revealing insights that may otherwise be inaccessible.
 
Further, as a global team, we travel extensively to industry events and companies to conduct in-depth, face-to-face interviews. We also engage with industry associations and follow public company filings as secondary sources. We conduct patent analysis and track regulatory changes and incentives. We consistently build on our decades-long research of emerging technologies.
 
We assess emerging technologies against existing solutions, evaluate market demand and provide data-driven forecasts based on our models. This provides a clear, unbiased outlook on the future of each technology or industry that we cover.

What is your forecast methodology?

We take into account the following information and data points where relevant to create our forecasts:
  • Historic data, based on our own databases of products, companies' sales data, information from associations, company reports and validation of our prior market figures with companies in the industry.
  • Current and announced manufacturing capacities
  • Company production targets
  • Direct input from companies as we interview them as to their growth expectations, moderated by our analysts
  • Planned or active government incentives and regulations
  • Assessment of the capabilities and price of the technology based on our benchmarking over the forecast period, versus that of competitive solutions
  • Teardown data (e.g. to assess volume of materials used)
  • From a top-down view: the total addressable market
  • Forecasts can be based on an s-curve methodology where appropriate, taking into account the above factors
  • Key assumptions and discussion of what can impact the forecast are covered in the report.

How can I be confident about the quality of work in IDTechEx reports?

Based on our technical analysts and their research methodology, for over 25 years our work has regularly received superb feedback from our global clients. Our research business has grown year-on-year.
 
Recent customer feedback includes:
"It's my first go-to platform"
- Dr. Didi Xu, Head of Foresight - Future Technologies, Freudenberg Technology Innovation
 
"Their expertise allows us to make data-driven, strategic decisions and ensures we remain aligned with the latest trends and opportunities in the market."
- Ralf Hug, Global Head of Product Management & Marketing, Marquardt

What differentiates IDTechEx reports?

Our team of in-house technical analysts immerse themselves in industries over many years, building deep expertise and engaging directly with key industry players to uncover hard-to-find insights. We appraise technologies in the landscape of competitive solutions and then assess their market demand based on voice-of-the-customer feedback, all from an impartial point of view. This approach delivers exceptional value to our customers—providing high-quality independent content while saving customers time, resources, and money.

Why should we pick IDTechEx research over AI research?

A crucial value of IDTechEx research is that it provides information, assessments and forecasts based on interviews with key people in the industry, assessed by technical experts. AI is trained only on content publicly available on the web, which may not be reliable, in depth, nor contain the latest insights based on the experience of those actively involved in a technology or industry, despite the confident prose.

How can I justify the ROI of this report?

Consider the cost of the IDTechEx report versus the time and resources required to gather the same quality of insights yourself. IDTechEx analysts have built up an extensive contact network over many years; we invest in attending key events and interviewing companies around the world; and our analysts are trained in appraising technologies and markets.
 
Each report provides an independent, expert-led technical and market appraisal, giving you access to actionable information immediately, rather than you having to spend months or years on your own market research.

Can I speak to analysts about the report content?

All report purchases include up to 30 minutes of telephone time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.

What is the difference between a report and subscription?

A subscription from IDTechEx can include more reports, access to an online information platform with continuously updated information from our analysts, and access to analysts directly.

Before purchasing, I have some questions about the report, can I speak to someone?

Please email research@idtechex.com stating your location and we will quickly respond.

About IDTechEx

Who are IDTechEx's customers?

IDTechEx has served over 35,000 customers globally. These range from large corporations to ambitious start-ups, and from Governments to research centers. Our customers use our work to make informed decisions and save time and resources.

Where is IDTechEx established?

IDTechEx was established in 1999, and is headquartered in Cambridge, UK. Since then, the company has significantly expanded and operates globally, having served customers in over 80 countries. Subsidiary companies are based in the USA, Germany and Japan.

Questions about purchasing a report

How do I pay?

In most locations reports can be purchased by credit card, or else by direct bank payment.

How and when do I receive access to IDTechEx reports?

When paying successfully by credit card, reports can be accessed immediately. For new customers, when paying by bank transfer, reports will usually be released when the payment is received. Report access will be notified by email.

How do I assign additional users to the report?

Users can be assigned in the report ordering process, or at a later time by email.

Can I speak to someone about purchasing a report?

Please email research@idtechex.com stating your location and we will quickly respond.
 
The market for bioelectronic medicine will exceed $60 billion by 2029.

Report Statistics

Slides 297
 

Customer Testimonial

quote graphic
"IDTechEx consistently provides well-structured and comprehensive research reports, offering a clear and holistic view of key trends... It's my first go-to platform for quickly exploring new topics and staying updated on industry advancements."
Head of Foresight - Future Technologies
Freudenberg Technology Innovation SE & Co. KG
 
 
 

Subscription Enquiry